162 related articles for article (PubMed ID: 33097695)
41. Epithelial V-like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB-PI3K-AKT pathway.
Ni Q; Chen Z; Zheng Q; Xie D; Li JJ; Cheng S; Ma X
Cancer Sci; 2020 May; 111(5):1500-1513. PubMed ID: 31997489
[TBL] [Abstract][Full Text] [Related]
42. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
43. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA THOR promotes cell proliferation and metastasis in hepatocellular carcinoma.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
Gene; 2018 Dec; 678():129-136. PubMed ID: 30098425
[TBL] [Abstract][Full Text] [Related]
45. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
47. Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Wu D; Li M; Tian W; Wang S; Cui L; Li H; Wang H; Ji A; Li Y
Sci Rep; 2017 Jul; 7(1):5134. PubMed ID: 28698660
[TBL] [Abstract][Full Text] [Related]
48. POU5F1B promotes hepatocellular carcinoma proliferation by activating AKT.
Pan Y; Zhan L; Chen L; Zhang H; Sun C; Xing C
Biomed Pharmacother; 2018 Apr; 100():374-380. PubMed ID: 29454285
[TBL] [Abstract][Full Text] [Related]
49. STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinoma.
Lan Y; Han J; Wang Y; Wang J; Yang G; Li K; Song R; Zheng T; Liang Y; Pan S; Liu X; Zhu M; Liu Y; Meng F; Mohsin M; Cui Y; Zhang B; Subash S; Liu L
Cell Death Dis; 2018 Feb; 9(2):236. PubMed ID: 29445189
[TBL] [Abstract][Full Text] [Related]
50. miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
Meng X; Lu P; Fan Q
Biochem Biophys Res Commun; 2016 Jan; 470(1):187-191. PubMed ID: 26772880
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
[TBL] [Abstract][Full Text] [Related]
52. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
[TBL] [Abstract][Full Text] [Related]
53. USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.
Lu C; Ning Z; Wang A; Chen D; Liu X; Xia T; Tekcham DS; Wang W; Li T; Liu X; Liu J; Qi H; Luo H; Du J; Ma C; Yan Q; Liu J; Xu G; Piao HL; Tan G
Cancer Lett; 2018 Nov; 436():139-148. PubMed ID: 30056112
[TBL] [Abstract][Full Text] [Related]
54. PI3K/AKT pathway activation in bladder carcinogenesis.
Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
[TBL] [Abstract][Full Text] [Related]
55. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer.
Li N; Men W; Zheng Y; Wang H; Meng X
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801250
[TBL] [Abstract][Full Text] [Related]
56. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20/PTEN pathway.
Tu W; Yang Y; Song Y; Zhu W
J Biochem; 2019 May; 165(5):423-431. PubMed ID: 30690477
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
59. DJ-1 knockdown inhibits growth and xenograft‑induced tumor generation of human hepatocellular carcinoma cells.
Liu S; Long G; Wei H; Shi L; Yang Z; Liu D; Hu G; Qiu H
Oncol Rep; 2015 Jan; 33(1):201-6. PubMed ID: 25384406
[TBL] [Abstract][Full Text] [Related]
60. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
